BG9924
Sponsors
Biogen
Conditions
Rheumatoid Arthritis
Phase 2
Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis
CompletedNCT00292422
Start: 2005-11-30End: 2007-05-31Updated: 2007-12-31
BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis
TerminatedNCT00458861
Start: 2007-03-31End: 2008-10-31Updated: 2016-01-21
BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)
TerminatedNCT00523328
Start: 2007-08-31End: 2008-10-31Updated: 2016-01-21